Schedule 13D ownership disclosure
Keros Therapeutics Inc
Security class unavailable · CUSIP: 492327101
Event date: 2023-12-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-23-001145
- Form type
- SC 13D
- Filer
- Keros Therapeutics, Inc.
- CIK
- CIK 1664710
- Filed
- Dec 13, 2023
- Reporting period
- Dec 11, 2023
- Description
- Schedule 13D beneficial ownership